To examine the relation between serum fatty acids and cancer, the authors conducted a nested casecontrol study of 108 middle-aged men who died of cancer and 215 men without cancer, who were enrolled in the Multiple Risk Factor Intervention Trial (MRFIT) between 1973 and 1976. Control subjects were matched to case subjects on age, smoking status, treatment assignment, date of randomization, and clinical center. After confirming the stability of the stored serum samples, the authors measured serum fatty acid levels by gas-liquid chromatography and analyzed their association with cancer. In stepwise logistic regression analyses that controlled for the MRFIT selection criteria variables and for alcohol consumption, no fatty acid was significantly associated with overall risk of cancer death (all p > 0.05). Serum levels of phospholipid dihomogammalinolenic acid (20:3), an essential fatty acid, were inversely associated with the risk of dying from lung cancer; a standard deviation increase was associated with a 32% decrease in risk (p = 0.05). Dietary cholesterol intake was associated with the risk of nonlung, non-digestive tract cancers; a standard deviation increase (331 mg/day) was associated with a 75% increase in risk (p = 0.02). The authors found no evidence to suggest that increased dietary intake or serum levels of polyunsaturated fatty acids were associated with an increased risk of fatal cancer among middle-aged men at high risk for coronary heart disease. The clinical significance of the inverse association between dihomogammalinolenic acid and lung cancer death is uncertain and requires confirmation. Am J Epidemiol 1998; 148:854-8. diet; fatty acids; neoplasms
Consumption of dietary fat may be causally associated with the risk of cancer. Some observational studies have reported an association between saturated fat consumption and the risk of breast, colon, and prostate cancers (1) . In laboratory animals, consumption of omega-6 polyunsaturated fatty acids, such as linoleic acid (18:2) , promotes tumor growth, while consumption of fish oils, rich in omega-3 polyunsaturated fatty acids, inhibits tumor growth (1) . Human population studies, however, have not found a consistent association between dietary polyunsaturated fatty acid intake and cancer (1) .
Because essential polyunsaturated fatty acids are derived solely from the diet, it may be possible to use serum levels of these fatty acids as indicators of dietary polyunsaturated fat intake (2, 3) . Serum levels of nonessential saturated and monounsaturated fatty acids are less reliable indicators of fatty acid consumption because they also reflect fatty acid synthesis and metabolism. Nevertheless, the association between individual fatty acids, which are highly correlated in the diet (4) , and cancer may be examined by measuring serum fatty acid levels. Using a nested design, we compared the baseline serum fatty acid levels of 108 men with fatal cancer with those of 215 controls who were enrolled in the Multiple Risk Factor Intervention Trial (MRFIT).
MATERIALS AND METHODS Subjects
The MRFIT was a primary coronary heart disease prevention trial among men at high risk for this disease. We defined cases (n = 108) as subjects who died of cancer during the study, an average 6.9 years of follow-up. We selected 215 men without cancer, stroke, or myocardial infarction during follow-up as controls, matching on age, smoking status, date of randomization, clinical center, and treatment assign-Fatty Acids and Cancer 855 ment. Medical records, next-of-kin interviews, death certificates, and autopsy reports were used to establish each death (5) . The International Classification of Diseases, Ninth Revision, was used to classify cancer deaths (6) . We grouped cases into three categories: digestive cancers (coded 142.1 through 157.9; n = 25); lung cancers (coded 162.9 and 239.1; n = 51); and all other cancers (n = 32).
Methods
A detailed description of the methods is provided elsewhere (7, 8) . Briefly, the self-reported level of education, smoking, and alcohol consumption were ascertained by questionnaire. Baseline weight and blood pressure measurements were made using standardized protocols, and nutrient intake was estimated using a 24-hour diet recall. Baseline fasting plasma lipids, lipoproteins, and glucose were measured. Analytical and quality control procedures used for the serum fatty acid measurements are described in detail elsewhere (7, 8) . We measured the fatty acid composition of serum cholesterol esters and phospholipids rather than serum triglyce/ides because of their longer half-life, reflecting a several week period of dietary intake (9, 10).
Statistical methods
We compared the means of continuous variables using matched pair t tests. We estimated the association of each variable with cancer death using conditional logistic regression (11) ; alcohol consumption and the nonmatched MRFIT selection criteria, plasma cholesterol level and diastolic blood pressure, were forced into all models. Multivariate models included other variables associated with cancer death at p < 0.20. These variables included dietary cholesterol and monounsaturated fat intake; the following fatty acids: phospholipid myristic acid (14:0), eicosadienoic acid (20:2), dihomogammalinolenic acid (20:3), and omega-3 docosahexaenoic acid (22:6); and cholesterol ester myristic acid (14:0) and stearic acid (18:0). We used a stepwise regression procedure to retain variables associated with cancer death at p < 0.05. This procedure was repeated with fatal digestive cancer, lung cancer, and other cancers as endpoints. We calculated odds ratios and 95 percent confidence intervals per estimated standard deviation in our sample (12) .
RESULTS
Participants in MRFIT were middle-aged men selected for their high levels of plasma cholesterol, diastolic blood pressure, and cigarette smoking. As a result, cases and controls were well-matched. We found no significant differences between groups in their mean baseline values, including reported levels of dietary consumption (all p > 0.05) (table 1).
The principal fatty acids in the serum cholesterol ester fraction were oleic acid (18:1) and linoleic acid (18:2) (table 2). We found a broader distribution of fatty acids in the phospholipid fraction, including the omega-3 polyunsaturated fatty acids eicosapentaenoic acid (20:5), docosapentaenoic acid (22:5), and docosahexaenoic acid (22:6).
There were no significant associations between serum fatty acid levels in either the cholesterol ester or phospholipid fractions and risk of fatal cancer (table  3) . Only the serum level of phospholipid myristic acid (14:0), a saturated fatty acid, was marginally associated with decreased cancer risk {p -0.06). However, this association was attenuated after further adjustment for variables associated with cancer at p < 0.20.
We examined the relation between serum fatty acid levels and the risk of fatal cancer by type of cancer (digestive, lung, and other). No serum fatty acid level 
DISCUSSION
Epidemiologic evidence in human populations suggests that total fat consumption is correlated with cancer risk (1). We found no association between total fat consumption and cancer mortality and did not detect an association between serum fatty acid levels and digestive cancers or other cancers.
We did, however, find that increasing levels of phospholipid dihomogammalinolenic acid (20:3), an omega-6 fatty acid, were marginally associated with a lower risk of fatal lung cancer, a cancer not usually associated with dietary fat intake (1). Although this association was most likely the result of chance, our results do concur, in part, with those of Zureik et al. (13) , who reported that a standard deviation increase in the serum cholesterol ester linoleic acid (18:2), the parent omega-6 polyunsaturated fatty acid, was associated with a 19 percent decreased risk of lung cancer death. Dihomogammalinolenic acid is a metabolite of linoleic acid, the principal dietary polyunsaturated fatty acid. Since naturally occurring oils contain minute amounts of dihomogammalinolenic acid (14) , consumption of foods rich in linoleic acid may increase serum dihomogammalinolenic acid levels. It is unclear how dihomogammalinolenic acid might be linked biologically with a decreased risk of lung cancer, since this fatty acid inhibits the production of interleukin-2 (15), a lymphokine with activity against some lung cancers (16).
Higher intakes of dietary cholesterol were associated with an increased risk for fatal nonlung, nondigestive tract cancers. Although not a consistent finding, the possible association of dietary cholesterol with cancer risk has been reported by several studies (1) . Animal studies have shown that dietary cholesterol diminishes tumor latency, affects the absorption of carcinogenic agents, and influences the interaction of carcinogens with DNA (17) . Although this is only the second prospective study to examine the relation of individual fatty acids to cancer risk (13) , there were limitations. Caution in generalizing from this relatively homogeneous sample of middle-aged American men is warranted. Although we assessed the stability of the stored frozen serum specimens and found little oxidative damage, we cannot exclude the possibility that an analysis of fresh serum samples would have demonstrated other associations. Our study had limited statistical power, as manifested by relatively wide confidence intervals. Using a 24-hour diet recall may provide an imprecise estimate of usual dietary intake. We performed many comparisons and cannot exclude chance as the cause of the two significant associations. We did not measure levels of trans-fatty acid isomers and cannot comment on the relation of these fatty acids to cancer. Other limitations include possible confounding by unmeasured dietary factors and limited ascertainment of variables potentially associated with cancer. Finally, cholesterol ester and phospholipid fatty acid levels may not reflect long-term dietary intake patterns (2) .
In conclusion, we found no evidence that increased serum levels of polyunsaturated fatty acids are associated with an increased risk of cancer. Our results suggest that cholesterol-rich foods may increase the risk of nonlung, non-digestive tract cancers, whereas foods rich in omega-6 polyunsaturated fatty acids may lower the risk of lung cancer, but these may be chance associations and require confirmation.
